Huiyu Pharmaceutical: Shareholder Wang Xiaopeng intends to reduce his shareholding by no more than 3%.

Huayu Pharmaceutical announced that shareholder Wang Xiaopeng intends to reduce his holdings of the company's shares by a total of no more than 12,708,000 shares, accounting for no more than 3% of the total equity of the company, through centralized bidding and block trading due to his own capital needs. Among them, the reduction through centralized bidding will not exceed 4.236 million shares, and the reduction through block trading will not exceed 8.472 million shares. The reduction period is from April 8, 2026 to July 6, 2026. The shares to be reduced are from the shares acquired before the company's initial public offering.